The Food and Drug Administration granted fast-track review for an over-the-counter overdose drug. The nonprofit pharmaceutical company Harm Reduction Therapeutics said in a release this week that the FDA had granted it priority review for a new drug application for RiVive, a naloxone nasal spray for emergency overdose treatment. (The Hill)
‘Pharma Bro’ Martin Shkreli advised Sam Bankman-Fried on his potential prison time, saying he should prepare by listening to rap music and shaving his head. “Shkreli, who was released from prison this year, told the crypto journalist Laura Shin on her podcast Unchained that he thinks Bankman-Fried “isn’t exactly gonna be somebody that fits into prison.” (Yahoo! News)
Four lots of blood pressure medication Quinapril were recalled over potential cancer risk, the FDA announced. Lupin Pharmaceuticals Inc.’s tablets, sold in 20 mg and 40 mg, may contain an elevated level of nitrosamine impurity, N-Nitroso-Quinapril, above the acceptable daily intake level. (USA Today)
BioNTech started a human trial to test its malaria vaccine. The Phase 1 trial is expected to enroll 60 volunteers in the United States with no history of malaria to assess the vaccine candidate at three-dose levels. (Reuters)
China announced it will start to open borders and relax coronavirus restrictions for foreign travelers. The relaxation of restrictions, starting Jan. 8, is the most significant move so far to reopen borders that have been all but closed for nearly three years. (The Washington Post)
